1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Discovery Grant Program (ALS and related neurological diseases)" is currently closed and not accepting applications.
Discovery Grant Program (ALS and related neurological diseases) is sponsored by Brain Canada Foundation. The Discovery Grant Program is designed to advance research on amyotrophic lateral sclerosis and related neurological diseases in Canada. It supports collaborative and translational projects that can identify disease causes, improve treatment approaches, and strengthen the quality of life for people and families living with ALS.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Research teams working on ALS and related neurological diseases in Canada. Encourages multidisciplinary teams. Confirm the full requirements in the official notice before applying.
The current listing shows seed Grant: Up to CAD 125,000 over two years; Development Grant: Up to CAD 500,000 over three years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 3, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Discovery Grant Program (ALS and related neurological diseases) is funded by Brain Canada Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
ARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleA Nature poll finds three-quarters of American scientists are considering working abroad. ERC applications from U.S. researchers have tripled. France and the EU pledged €500 million to recruit them. Inside the brain drain reshaping global science — and what it means for grant strategy.
Read article